{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T05:06:26Z","timestamp":1738818386928,"version":"3.37.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"crossref","award":["CSTB2022NSCQ-BHX0022","CSTB2024NSCQ-LZX0008"],"award-info":[{"award-number":["CSTB2022NSCQ-BHX0022","CSTB2024NSCQ-LZX0008"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32371030"],"award-info":[{"award-number":["32371030"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CQMU Program for Youth Innovation in Future Medicine","award":["W0044"],"award-info":[{"award-number":["W0044"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-024-09852-4","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T12:02:22Z","timestamp":1723636942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sofalcone attenuates neurodegeneration in MPTP-induced mouse model of Parkinson\u2019s disease by inhibiting oxidative stress and neuroinflammation"],"prefix":"10.1007","volume":"51","author":[{"given":"Mulan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yepeng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"key":"9852_CR1","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.neurol.2019.11.002","volume":"176","author":"A Draoui","year":"2020","unstructured":"Draoui A, El Hiba O, Aimrane A, El Khiat A, Gamrani H (2020) Parkinson\u2019s disease: from bench to bedside. Rev Neurol (Paris) 176:543\u2013559","journal-title":"Rev Neurol (Paris)"},{"key":"9852_CR2","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","volume":"363","author":"A Samii","year":"2004","unstructured":"Samii A, Nutt JG, Ransom BR (2004) Parkinson\u2019s disease. Lancet 363:1783\u20131793","journal-title":"Lancet"},{"issue":"Suppl 1","key":"9852_CR3","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.parkreldis.2017.07.033","volume":"46","author":"DW Dickson","year":"2018","unstructured":"Dickson DW (2018) Neuropathology of Parkinson disease. Parkinsonism Relat Disord 46(Suppl 1):S30\u2013S33","journal-title":"Parkinsonism Relat Disord"},{"key":"9852_CR4","doi-asserted-by":"crossref","unstructured":"Chakrabarti S, Bisaglia M (2023) Oxidative Stress and Neuroinflammation in Parkinson\u2019s Disease: The Role of Dopamine Oxidation Products. Antioxid (Basel) 12","DOI":"10.3390\/antiox12040955"},{"key":"9852_CR5","doi-asserted-by":"crossref","unstructured":"He J, Zhu G, Wang G, Zhang F (2020) Oxidative Stress and Neuroinflammation Potentiate Each Other to Promote Progression of Dopamine Neurodegeneration. Oxid Med Cell Longev. 2020: 6137521","DOI":"10.1155\/2020\/6137521"},{"key":"9852_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2016.07.005","volume":"147","author":"T Jiang","year":"2016","unstructured":"Jiang T, Sun Q, Chen S (2016) Oxidative stress: a major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson\u2019s disease and Alzheimer\u2019s disease. Prog Neurobiol 147:1\u201319","journal-title":"Prog Neurobiol"},{"key":"9852_CR7","doi-asserted-by":"publisher","first-page":"172722","DOI":"10.1016\/j.ejphar.2019.172722","volume":"865","author":"W Kim","year":"2019","unstructured":"Kim W, Lee H, Kim S, Joo S, Jeong S, Yoo JW et al (2019) Sofalcone, a gastroprotective drug, covalently binds to KEAP1 to activate Nrf2 resulting in anti-colitic activity. Eur J Pharmacol 865:172722","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 1","key":"9852_CR8","first-page":"S155","volume":"25","author":"K Higuchi","year":"2010","unstructured":"Higuchi K, Watanabe T, Tanigawa T, Tominaga K, Fujiwara Y, Arakawa T (2010) Sofalcone, a gastroprotective drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori: a randomized controlled comparative trial with cimetidine, an H2-receptor antagonist. J Gastroenterol Hepatol 25(Suppl 1):S155\u2013160","journal-title":"J Gastroenterol Hepatol"},{"key":"9852_CR9","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1161\/HYPERTENSIONAHA.114.04781","volume":"65","author":"K Onda","year":"2015","unstructured":"Onda K, Tong S, Nakahara A, Kondo M, Monchusho H, Hirano T et al (2015) Sofalcone upregulates the nuclear factor (erythroid-derived 2)-like 2\/heme oxygenase-1 pathway, reduces soluble fms-like tyrosine kinase-1, and quenches endothelial dysfunction: potential therapeutic for preeclampsia. Hypertension 65:855\u2013862","journal-title":"Hypertension"},{"key":"9852_CR10","doi-asserted-by":"crossref","unstructured":"Krolicka E, Kiec-Kononowicz K, Lazewska D (2022) Chalcones as Potential Ligands for the Treatment of Parkinson\u2019s Disease. Pharmaceuticals (Basel) 15","DOI":"10.3390\/ph15070847"},{"key":"9852_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41418-021-00900-1","volume":"29","author":"G Rona","year":"2022","unstructured":"Rona G, Zeke A, Miwatani-Minter B, de Vries M, Kaur R, Schinlever A et al (2022) The NSP14\/NSP10 RNA repair complex as a pan-coronavirus therapeutic target. Cell Death Differ 29:285\u2013292","journal-title":"Cell Death Differ"},{"key":"9852_CR12","doi-asserted-by":"publisher","first-page":"112231","DOI":"10.1016\/j.celrep.2023.112231","volume":"42","author":"DJ Vidyadhara","year":"2023","unstructured":"Vidyadhara DJ, Somayaji M, Wade N, Yucel B, Zhao H, Shashaank N et al (2023) Dopamine transporter and synaptic vesicle sorting defects underlie auxilin-associated Parkinson\u2019s disease. Cell Rep 42:112231","journal-title":"Cell Rep"},{"key":"9852_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","volume":"508","author":"SC Daubner","year":"2011","unstructured":"Daubner SC, Le T, Wang S (2011) Tyrosine hydroxylase and regulation of dopamine synthesis. Arch Biochem Biophys 508:1\u201312","journal-title":"Arch Biochem Biophys"},{"key":"9852_CR14","doi-asserted-by":"crossref","unstructured":"Tryphena KP, Nikhil US, Pinjala P, Srivastava S, Singh SB, Khatri DK (2023) Mitochondrial Complex I as a Pathologic and Therapeutic Target for Parkinson\u2019s Disease. ACS Chem Neurosci","DOI":"10.1021\/acschemneuro.2c00819"},{"key":"9852_CR15","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.freeradbiomed.2008.09.001","volume":"45","author":"HE de Vries","year":"2008","unstructured":"de Vries HE, Witte M, Hondius D, Rozemuller AJ, Drukarch B, Hoozemans J et al (2008) Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease? Free Radic Biol Med 45:1375\u20131383","journal-title":"Free Radic Biol Med"},{"key":"9852_CR16","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3389\/fphar.2019.01008","volume":"10","author":"L Guzman-Martinez","year":"2019","unstructured":"Guzman-Martinez L, Maccioni RB, Andrade V, Navarrete LP, Pastor MG, Ramos-Escobar N (2019) Neuroinflammation as a common feature of neurodegenerative disorders. Front Pharmacol 10:1008","journal-title":"Front Pharmacol"},{"key":"9852_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"HS Kwon","year":"2020","unstructured":"Kwon HS, Koh SH (2020) Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener 9:42","journal-title":"Transl Neurodegener"},{"key":"9852_CR18","doi-asserted-by":"crossref","unstructured":"Pajares M, Manda AIR, Bosca G, Cuadrado L (2020) A. Inflammation in Parkinson\u2019s Disease: Mechanisms and Therapeutic Implications. Cells 9","DOI":"10.3390\/cells9071687"},{"key":"9852_CR19","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.bbrc.2009.02.086","volume":"381","author":"H Tanaka","year":"2009","unstructured":"Tanaka H, Nakamura S, Onda K, Tazaki T, Hirano T (2009) Sofalcone, an anti-ulcer chalcone derivative, suppresses inflammatory crosstalk between macrophages and adipocytes and adipocyte differentiation: implication of heme-oxygenase-1 induction. Biochem Biophys Res Commun 381:566\u2013571","journal-title":"Biochem Biophys Res Commun"},{"key":"9852_CR20","doi-asserted-by":"publisher","first-page":"14363","DOI":"10.1523\/JNEUROSCI.3928-08.2008","volume":"28","author":"C Malagelada","year":"2008","unstructured":"Malagelada C, Jin ZH, Greene LA (2008) RTP801 is induced in Parkinson\u2019s disease and mediates neuron death by inhibiting akt phosphorylation\/activation. J Neurosci 28:14363\u201314371","journal-title":"J Neurosci"},{"key":"9852_CR21","first-page":"19","volume":"2","author":"Y Liao","year":"2010","unstructured":"Liao Y, Hung MC (2010) Physiological regulation of akt activity and stability. Am J Transl Res 2:19\u201342","journal-title":"Am J Transl Res"},{"key":"9852_CR22","doi-asserted-by":"publisher","first-page":"648636","DOI":"10.3389\/fphar.2021.648636","volume":"12","author":"HZ Long","year":"2021","unstructured":"Long HZ, Cheng Y, Zhou ZW, Luo HY, Wen DD, Gao LC (2021) PI3K\/AKT Signal Pathway: a target of Natural products in the Prevention and Treatment of Alzheimer\u2019s Disease and Parkinson\u2019s Disease. Front Pharmacol 12:648636","journal-title":"Front Pharmacol"},{"key":"9852_CR23","doi-asserted-by":"crossref","unstructured":"Liu Y, Geng L, Zhang J, Wang J, Zhang Q, Duan D et al (2018) Oligo-porphyran ameliorates neurobehavioral deficits in Parkinsonian mice by regulating the PI3K\/Akt\/Bcl-2 pathway. Mar Drugs 16","DOI":"10.3390\/md16030082"},{"key":"9852_CR24","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.ijbiomac.2017.05.162","volume":"104","author":"B Mathew","year":"2017","unstructured":"Mathew B, Mathew GE, Ucar G, Joy M, Nafna EK, Lohidakshan KK et al (2017) Monoamine oxidase inhibitory activity of methoxy-substituted chalcones. Int J Biol Macromol 104:1321\u20131329","journal-title":"Int J Biol Macromol"},{"key":"9852_CR25","doi-asserted-by":"publisher","first-page":"e0169560","DOI":"10.1371\/journal.pone.0169560","volume":"12","author":"H Jing","year":"2017","unstructured":"Jing H, Wang S, Wang M, Fu W, Zhang C, Xu D (2017) Isobavachalcone attenuates MPTP-Induced Parkinson\u2019s Disease in mice by inhibition of Microglial activation through NF-kappaB pathway. PLoS ONE 12:e0169560","journal-title":"PLoS ONE"},{"key":"9852_CR26","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1007\/s11064-020-03130-y","volume":"45","author":"DGT Parambi","year":"2020","unstructured":"Parambi DGT, Saleem U, Shah MA, Anwar F, Ahmad B, Manzar A et al (2020) Exploring the therapeutic potentials of highly selective oxygenated chalcone based MAO-B inhibitors in a Haloperidol-Induced Murine Model of Parkinson\u2019s Disease. Neurochem Res 45:2786\u20132799","journal-title":"Neurochem Res"},{"key":"9852_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.31083\/j.fbe1404027","volume":"14","author":"J Melrose","year":"2022","unstructured":"Melrose J, Smith MM (2022) Natural and semi-synthetic flavonoid Anti-SARS-CoV-2 agents for the treatment of long COVID-19 Disease and neurodegenerative disorders of Cognitive decline. Front Biosci (Elite Ed) 14:27","journal-title":"Front Biosci (Elite Ed)"},{"key":"9852_CR28","doi-asserted-by":"crossref","unstructured":"Percario S, da Silva Barbosa A, Varela ELP, Gomes ARQ, de Ferreira MES et al (2020) Nazare Araujo Moreira T, Oxidative Stress in Parkinson\u2019s Disease: Potential Benefits of Antioxidant Supplementation. Oxid Med Cell Longev. 2020: 2360872","DOI":"10.1155\/2020\/2360872"},{"key":"9852_CR29","doi-asserted-by":"publisher","first-page":"102389","DOI":"10.1016\/j.redox.2022.102389","volume":"54","author":"S Liu","year":"2022","unstructured":"Liu S, Pi J, Zhang Q (2022) Signal amplification in the KEAP1-NRF2-ARE antioxidant response pathway. Redox Biol 54:102389","journal-title":"Redox Biol"},{"key":"9852_CR30","doi-asserted-by":"publisher","first-page":"318","DOI":"10.4274\/balkanmedj.galenos.2022.2022-7-100","volume":"39","author":"E Cinar","year":"2022","unstructured":"Cinar E, Tel BC, Sahin G (2022) Neuroinflammation in Parkinson\u2019s Disease and its Treatment opportunities. Balkan Med J 39:318\u2013333","journal-title":"Balkan Med J"},{"key":"9852_CR31","doi-asserted-by":"publisher","first-page":"8981","DOI":"10.1039\/D3CC00577A","volume":"59","author":"T Yang","year":"2023","unstructured":"Yang T, Liu D, Li Y, Zhang Y, Zhu Y, Zhang J et al (2023) Chemoproteomics reveals Sofalcone inhibits the inflammatory response of Caco-2 cells by covalently targeting HMGB1. Chem Commun (Camb) 59:8981\u20138984","journal-title":"Chem Commun (Camb)"},{"key":"9852_CR32","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3858\/emm.2012.44.6.042","volume":"44","author":"YH Lee","year":"2012","unstructured":"Lee YH, Jeon SH, Kim SH, Kim C, Lee SJ, Koh D et al (2012) A new synthetic chalcone derivative, 2-hydroxy-3\u2019,5,5\u2019-trimethoxychalcone (DK-139), suppresses the toll-like receptor 4-mediated inflammatory response through inhibition of the Akt\/NF-kappaB pathway in BV2 microglial cells. Exp Mol Med 44:369\u2013377","journal-title":"Exp Mol Med"},{"key":"9852_CR33","doi-asserted-by":"crossref","unstructured":"Zhang W, He H, Song H, Zhao J, Li T, Wu L et al (2016), Neuroprotective Effects of Salidroside in the MPTP Mouse Model of Parkinson\u2019s Disease: Involvement of the PI3K\/Akt\/GSK3beta Pathway. Parkinsons Dis. 2016: 9450137","DOI":"10.1155\/2016\/9450137"},{"key":"9852_CR34","doi-asserted-by":"publisher","first-page":"113451","DOI":"10.1016\/j.jep.2020.113451","volume":"266","author":"M Zheng","year":"2021","unstructured":"Zheng M, Chen M, Liu C, Fan Y, Shi D (2021) Alkaloids extracted from Uncaria rhynchophylla demonstrate neuroprotective effects in MPTP-induced experimental parkinsonism by regulating the PI3K\/Akt\/mTOR signaling pathway. J Ethnopharmacol 266:113451","journal-title":"J Ethnopharmacol"},{"key":"9852_CR35","doi-asserted-by":"publisher","first-page":"6076","DOI":"10.1007\/s12035-017-0798-6","volume":"55","author":"T Ali","year":"2018","unstructured":"Ali T, Kim T, Rehman SU, Khan MS, Amin FU, Khan M et al (2018) Natural dietary supplementation of anthocyanins via PI3K\/Akt\/Nrf2\/HO-1 pathways mitigate oxidative stress, neurodegeneration, and memory impairment in a mouse model of Alzheimer\u2019s Disease. Mol Neurobiol 55:6076\u20136093","journal-title":"Mol Neurobiol"},{"key":"9852_CR36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12974-019-1474-8","volume":"16","author":"LT Guo","year":"2019","unstructured":"Guo LT, Wang SQ, Su J, Xu LX, Ji ZY, Zhang RY et al (2019) Baicalin ameliorates neuroinflammation-induced depressive-like behavior through inhibition of toll-like receptor 4 expression via the PI3K\/AKT\/FoxO1 pathway. J Neuroinflammation 16:95","journal-title":"J Neuroinflammation"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09852-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-09852-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09852-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T04:04:09Z","timestamp":1738728249000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-09852-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9852"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-09852-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2024,8,14]]},"assertion":[{"value":"14 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were conducted in accordance with the Chongqing Science and Technology Commission guidelines and approved by the Animal Ethics Committee of Children\u2019s Hospital of Chongqing Medical University (Approval number: CHCMU-IACUC20220323014).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"908"}}